Forward | Notice from the Office of the National Medical Products Administration on Holding a Training Course on Reproductive and Genetic Toxicity Evaluation Strategies and Case Sharing
2026/06/15
- Pre：Drug Regulatory News | CDE Issues Notices on "Major Deficiencies in Pharmaceutical Research of Chemical Generic Drugs" and "Major Deficiencies in Bioequivalence Research of Chemical Generic Drugs"
- Next：Drug Regulatory News | China National Medical Products Administration's Drug Evaluation Center Issues the "Annual Report on the Progress of New Drug Clinical Trials in China (2025)"
